Perspectives on Cancer Genome Profiling


Liquid Biopsy: Addressing the need, when tissue is an issue

For oncologists, molecular testing of tissue biopsies currently remains the gold standard for best understanding a patient’s disease and recommending treatment modalities. Unfortunately, there are multiple scenarios where tissue is not available or of sufficient quantity and quality for testing. For example, 10-25% of NSCLC patients may have an insufficient tissue for…

The Fault in Our DNA

“What am I at war with? My cancer. And what is my cancer? My cancer is me.  The tumors are made of me.  They’re made of me as surely as my brain and my heart are made of me.  It is a civil war… with a predetermined winner.”- John GreenEach one of…